Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study.

Xiaoyan Ma,Lu Fang,Lili Sheng,Xun Zhou,Shoujun Bai,Xiujuan Zang,Yakun Wang, Mengke Li,Zexin Lv,Qin Zhong,Xinyu Yang,Yishu Wang, Yan Hu,Danying Yan,Yingfeng Shi, Hui Chen,Jinqing Li,Min Tao,Shougang Zhuang,Yi Wang,Na Liu

Renal failure（2023）

引用 0|浏览11

暂无评分

摘要

RTX appears to be effective in RNS across various clinical and pathological subtypes, exhibiting a low relapse rate and minimal significant side effects in the majority of patients.

查看译文

关键词

rituximab treatment,refractory nephrotic syndrome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要